Novartis AG and Nestlé S.A. have completed the purchase and sale of approximately 156 million shares of Alcon, Inc. for $28.3 billion in cash. Novartis is now Alcon’s majority shareholder, controlling approximately 77% of Alcon’s shares. Novartis is still working to acquire the rest of the company’s shares. The five Nestlé members of the Alcon board of directors have resigned and the August 16, 2010 election of the five Novartis-designated directors is in effect. “I would like to thank Nestlé...